Linking RAGE and Nox in diabetic micro- and macrovascular complications

Diabetes & Metabolism
C KoulisKarin Jandeleit-Dahm

Abstract

Diabetes-associated micro- and macrovascular complications contribute to the increased morbidity and mortality observed in diabetes. Diabetes leads to accelerated generation of advanced glycation end products (AGEs) and activation of their receptor, RAGE, as well as activation of NAD(P)H oxidase (Nox), an enzyme dedicated to the production of reactive oxygen species, which ultimately leads to a pro-inflammatory environment characterised by oxidative stress. This review outlines the current evidence about the contribution of and interaction between the AGE-RAGE axis and Nox derived ROS formation in the development and progression of micro- and macrovascular diabetic complications (especially in atherosclerosis and nephropathy), and the mechanisms by which this occurs. We also outline novel treatments targeting the AGE-RAGE axis and specific Nox isoforms, which hold great promise in attenuating the development of diabetes-associated atherosclerosis and diabetic nephropathy.

References

Feb 13, 2001·Biochemical and Biophysical Research Communications·W ZhuS Horiuchi
Jul 18, 2001·The Journal of Clinical Investigation·Y YamamotoH Yamamoto
Oct 3, 2001·The Journal of Clinical Investigation·A M SchmidtD M Stern
Nov 27, 2002·Circulation·Loredana G BucciarelliAnn Marie Schmidt
Oct 22, 2003·Archives of Biochemistry and Biophysics·Paul J Thornalley
Jul 31, 2004·Journal of the American Society of Nephrology : JASN·Markus LassilaKarin A M Jandeleit-Dahm
Oct 19, 2004·Microbes and Infection·Triantafyllos ChavakisPeter P Nawroth
Mar 21, 2006·Cardiovascular Research·Henrik ten FreyhausStephan Rosenkranz
Sep 22, 2006·Antioxidants & Redox Signaling·Pritmohinder S Gill, Christopher S Wilcox
Apr 25, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Jaime UribarriHelen Vlassara
Dec 15, 2007·The Journal of Clinical Investigation·Evis HarjaAnn Marie Schmidt
Dec 19, 2007·Hypertension·Rhian M Touyz
Dec 19, 2007·Hypertension·Sabine HeumüllerRalf P Brandes
Feb 23, 2008·Clinical and Experimental Pharmacology & Physiology·Karin Jandeleit-DahmAino Soro-Paavonen
May 14, 2008·Current Pharmaceutical Design·Karin Jandeleit-Dahm, Mark E Cooper
May 20, 2008·Seminars in Immunopathology·Tomoko Kakehi, Chihiro Yabe-Nishimura
Oct 16, 2008·Current Drug Metabolism·Elisabetta AldieriDario Ghigo
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Karen BlockHanna E Abboud
Sep 4, 2009·Internal and Emergency Medicine·Natale VazzanaGiovanni Davì
Jul 24, 2010·European Journal of Clinical Investigation·Martin BuschGunter Wolf

❮ Previous
Next ❯

Citations

Mar 26, 2016·Molecular Aspects of Medicine·Giuseppe MaulucciShlomo Sasson
Jun 18, 2016·Oxidative Medicine and Cellular Longevity·S PirasM Nitti
Jun 25, 2016·Glycoconjugate Journal·Sho-Ichi YamagishiKei Fukami
Aug 25, 2016·Journal of Diabetes·Sho-Ichi YamagishiTakanori Matsui
Sep 17, 2020·Critical Reviews in Biochemistry and Molecular Biology·Nitish JangdeVivek Rai
May 11, 2018·Journal of Diabetes Research·Ying-Hua ChenBo Feng
May 26, 2018·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Soyeon LimSungha Park
Aug 30, 2019·IBRO Reports·Sumit BaruaJong Eun Lee
Feb 9, 2021·Journal of Physiology and Biochemistry·Mehdi KaramianMina Hemmati
Dec 8, 2020·Oxidative Medicine and Cellular Longevity·Kai WangLuyu Zhou
Dec 12, 2020·Frontiers in Endocrinology·Teng MengBaohua Liu
Sep 26, 2020·Cell Biochemistry and Function·Bhargav N WaghelaChandramani Pathak
Feb 24, 2021·European Journal of Clinical Investigation·Joanna NatorskaAnetta Undas
Jul 8, 2021·Clinical Science·Timothy M Palmer, Ian P Salt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiac Amyloidosis

Cardiac amyloidosis is a myocardial disease characterized by extracellular amyloid infiltration throughout the heart. Discover the latest research on cardiac amyloidosis here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Related Papers

Expert Review of Endocrinology & Metabolism
Stephen P GrayKarin Jandeleit-Dahm
Journal of Diabetes Science and Technology
Shivananda NayakStephanie Mohammed
The International Journal of Biochemistry & Cell Biology
Christina PiperiAthanasios G Papavassiliou
© 2021 Meta ULC. All rights reserved